- The USPTO issues two patents to Vivus (NASDAQ:VVUS) covering methods for effecting weight loss using Qsymia (phentermine an topiramate extended-release) (No. 8,895,057) and compositions of Qsymia (No. 8,895,058). The patents will be added to the Orange Book shortly.